Near Record Numbers On Wall Street Say Stocks Again "Overvalued"; Just 14% Believe In A V-Shaped Recovery
3 Dow Jones Stocks That Look Strong Despite Market Uncertainty
'COVID Secured': Over 15% Of Tesla Employees Affected After Musk's Early Reopening
NYC Recovery Stalling As Consumer Activity Levels Underwhelm
Extending Production Cuts Would Be "Suicidal" For OPEC
If we love our cities, we'll make better decisions about their future after the COVID-19 pandemic
El-Erian Warns "Financial Stress From COVID Is Far From Over"
Building back better after COVID-19: How social protection can help countries prepare for the impacts of climate change
Bill Gross Is COVID-Free And "Betting The Farm" On Value Over Growth
To keep development goals in sight, policymakers need to fan the embers of productivity growth
Technically Speaking: “Golden Cross” Arrives, Are The Bulls Safe?
US Open – JP Morgan paints bright picture for other banks, Delta slashes August flights, Oil’s taper tantrum, Gold consolidates
Several Hard-Hit Sectors Reverse Previous Price Drops in June
New Book Update
JPM Beats Expectations On Record Trading Revenue As Credit Loss Charges Soar Above $10BN
Global Stocks Slide, Futures Flat As China Sanctions Lockheed, Virus Fears Grow
Nasdaq Sends Warning Signs
Concorde 2.0? Boom Supersonic To Unveil Ultrafast Plane In October
US Recovery Stalls As Pandemic 'Second Wave' Threatens To Unleash Double-Dip Recession
Taleb: Tail-Risk Hedges Are Now A Necessity
When pandemic-related forbearance programs end, servicers will be faced with default inventory
Spotting trends: Sectors to consider in a changed world
The Higher The Number Of Covid Cases, And The More Layoffs, The More Bullish It Is For Stocks
Facts or fake news: Revealing patterns in the COVID-19 tweets of Trudeau and Trump
EUR/USD continues upward trend as markets hesitate
EU members bicker over massive recovery fund
Airlines got travelers comfortable about flying again once before – but 9/11 and a virus are a lot different
South Korea: 1 in 3 Covid-19 Patients Improved With Gilead’s Remdesivir
Futures Jump Above 3,200 On Vaccine Optimism, Merger Monday
Your coping and resilience strategies might need to shift as the COVID-19 crisis continues